OMAHA, Neb.– Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced a research agreement with the University of Melbourne to conduct additional clinical validation studies of its Multiplexed ICE COLD-PCRTM (MX-ICP) technology. MX-ICP is a high […]
SUNNYVALE, Calif. and GENEVA, Switzerland — Cepheid (Nasdaq: CPHD), FIND, and Rutgers New Jersey Medical School, today announced details of a collaboration to develop Xpert® MTB/RIF Ultra, a next-generation test for Mycobacterium tuberculosis (TB) with increased sensitivity to aid in detection of patients with smear-negative TB, which is often associated with HIV co-infection. The collaboration […]
Buffalo Grove, Ill. –– Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today that it has entered into a definitive agreement to acquire Devicor Medical Products, Inc. Devicor is a global market leader in breast biopsy instruments and consumables, with annual revenues of approximately $170 million. Devicor, headquartered in Cincinnati, […]
Hilden, Germany, and Tokyo, Japan -— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a master collaboration agreement with Astellas Pharma Inc., an R&D-driven global pharmaceutical company headquartered in Japan, to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. The scope of the agreement is […]
Hilden, Germany, and Barcelona, Spain -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced its support for the implementation of new guidelines presented today by the World Health Organization (WHO) as part of its Post-2015 Global Tuberculosis Strategy (End TB). This strategy document outlines a 20-year blueprint and now includes new guidelines that […]
Buffalo Grove, Ill. –– Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today that it has entered into a definitive agreement to acquire Devicor Medical Products, Inc. Devicor is a global market leader in breast biopsy instruments and consumables, with annual revenues of approximately $170 million. Devicor, headquartered in Cincinnati, […]
Oxford Gene Technology (OGT), the molecular genetics company, today announced it is initiating a clinical trial of a new microarray-based non-invasive prenatal test (NIPT) for Down’s syndrome. OGT has developed proprietary microarray technology which has significant advantages over next generation sequencing (NGS). Time to result is reduced from up to ten days to less than […]
Fremont, Calif., –– National, state and local representatives joined Thermo Fisher Scientific officials today to dedicate a new $85 million Niche Diagnostics Center of Excellence in Fremont, California. United States Congressmen Mike Honda and Eric Swalwell, California Assemblyman Bob Wieckowski, California State Senator Ellen Corbett, Director of the Governor’s Office of Business and Economic Development […]
Alameda, Calif. –– Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today outlined a refinement of the Company’s commercial strategy which will expand its Clinical Lab Testing Services direct sales force throughout the United States. In conjunction with this expansion, Singulex also announced the […]
SEATTLE — NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that the Journal of Clinical Oncology published an analysis of data in over 2,100 patients showing that the risk-of-recurrence (ROR) score generated by the PAM50-based Prosigna™ Breast Cancer Assay predicts the risk of late […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
